Conference Update 2: Electric Boogaloo There's a woman

New Post Public Reply Private Reply Replies (1) Message Board
Respert24
664
Conference Update 2: Electric Boogaloo

There's a woman giving a talk on implicit bias and she's doing a terrible job. She's running like, three different conversations at once. There's the general direction of the talk about implicit bias, with constant and out of the blue diversions to discussions she's had with people on this topic, sprinkled with even more random diversions to conversations she's had with her family. It's really hard to follow and reminds me that not everyone can Respert, but many people can Craig.

I remember having to go through four different personality training courses with four different companies I worked for over the years. The kind of thing where you learn about you and your customers personalities in hopes that you can better sell to their style/personality and improve your results as a, well, result.

I'll spare you where I always fell (the best traits) and just tell you about one of my coworkers back in the day, which is why I brought this up. She got done assessing herself and the results were hilarious. We, as teammates, knew her to be a bummer of a person. The opposite of charismatic. She had resting bitch face, was aggressively materialistic and condescending. No fun at all. A real Craig, in many ways.

Turns out she assessed herself as a fun, airy, life of the party type. She didn't have any of the things we all saw every day.

Which makes me wonder how much a Craig really knows they're Craiging. Or if they think they're absolutely slaying it, and walk around their mom's basement confused why people are getting the read on them so wrong.

Speaking of reads, Cytodyn has been elusive to nail down. While not all their fault (Amarex, FDA, 13D'bags, Craigs) there have been a lot of self inflicted wounds (Nader) over the years and we all pretty much swung and missed on what we thought we knew about them, the timing to market, or a handful of other things. But while they're less communicative now, it's becoming easier to know what we've got in them.

Hindsight is 2020, and I mean that in two ways because in hindsight we all had a chance to cash some shares out for a nice price in 2020. We don't have that luxury right now, but I trust the company to move back in that direction more than ever. No matter what the Craigs say.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Island Pacific Opens 22nd Store in Eagle Rock, L.A.

Updated Category News Views 85

Winning the Grocery Game One Store at a Time Here's the scoop—Island Pacific Seafood Market just rolled up the shutters on their 22nd supermarket at 4044 N. Eagle Rock Boulevard in the bustling hub of Glassell Park, Los Angeles. This ain't just some ho-hum store opening; it's a celebration rooted in Filipino heritage, smack in the middle of Northeast L.A., where culture...

Continue Reading
Singapore Welcomes IASO Bio's Pioneering BCMA CAR-T Therapy

Updated Category News Views 100

IASO Bio’s done it—they've taken a leap into Singapore with their fully human BCMA-targeted CAR-T cell therapy, FUCASO. November 3 was the official launch day, a big moment in Southeast Asia’s healthcare hub. And we're not just talking any therapy. This is a world-first fully human BCMA CAR-T hitting Singapore's market after getting the nod from the Health Sciences...

Continue Reading
KFC Teams with Marvel for Record-Breaking Menu Launch

Updated Category News Views 132

Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...

Continue Reading
Taiwan's Bold Bid: From Tech Hub to Capital Magnet

Updated Category News Views 37

Ambitious Plans Unveiled at Taiwan Weeks 2026 Forget the usual humdrum; Taiwan’s pulling no punches in its bid to become a capital powerhouse in Asia. If you'd told me years ago that Taiwan was eyeing dominance in asset management, I might've laughed. But at the 2026 Taiwan Weeks, they showed they're dead serious about it. Over 400 bigwigs and market shakers gathered,...

Continue Reading
LIME Faces Investigation Amid Earnings Shortfall

Updated Category News Views 36

Financial Miss Spurs Investigation When you've been in this racket as long as I have, you learn that missing consensus earnings even by a few cents can stir up a financial hornet's nest. That's precisely where Neutron Holdings Inc., better known as Lime, finds itself. With their third-quarter earnings slipping two cents below expectation, at $0.63 against a $0.66 to $0.68...

Continue Reading
SensAI Veritas Unveils New Risk Intelligence Tools

Updated Category News Views 0

Transforming Security Assessments with SensAI Security screenings are about to get a serious upgrade with SensAI Veritas rolling out their latest toys—the SensAI Gateway™ and Helm™. Forget what you knew about traditional identity checks; this is all about diving deeper to sniff out those hidden risks before anyone gets a green light. From Static Checks to Dynamic...

Continue Reading
Saga Metals Advances Radar Project with HQ Drill Success

Updated Category News Views 117

Digging Deep at Trapper North: Saga's Strategic Drill Move There's nothing like the thrill of discovery, especially in the rough-and-tumble world of mining exploration. Saga Metals Corp., anchored deep in the critical minerals scene, has wrapped up an HQ-diameter drill program at its Radar Project, smack dab near Cartwright, Labrador. You hear 1,010 meters and maybe...

Continue Reading
GaNrich: Gallium Nitride Game-Changer Expands Global Reach

Updated Category News Views 11

Rattling the Silicon Cage: GaNrich's Transformative Climb Well, folks, here's a story that makes even the most stoic traders sit up and take notice: GaNrich Semiconductor, a Taiwan-based trailblazer, is serving a wallop to the traditional silicon power device monopoly. By expanding their GaN power device portfolio to cover voltages ranging a whopping 40V to 1200V, GaNrich...

Continue Reading
Ecobat Workers Secure Landmark Three-Year Contract

Updated Category News Views 34

A Breakthrough for Ecobat Workers Man, when it comes to contracts, this recent deal at Ecobat is as game-changing as they get. A vote just ripped through like a hurricane, with 220 workers under Teamsters Local 986 eagerly ratifying a new three-year agreement that signals more than just a better payday. We're talking the largest wage boost these folks have clapped eyes on...

Continue Reading
Flexcompute's Physics Twin Revolutionizes Space Docking

Updated Category News Views 65

There's a new player shaking up the space game, and it's called the Physics Twin. Flexcompute, a trailblazer in AI-driven physics modeling, just rolled this out to help figure out how thruster plumes mess with nearby spacecraft. Trust me, this ain't your garden-variety simulation tool. Why Thruster Plumes Matter If you're in the business of dancing spacecraft around each...

Continue Reading

Top 5 Most Recently Viewed Articles

Citi Confirms Positive Outlook for Alnylam Pharmaceuticals' Growth

Updated Category News Views 112

Citi Confirms Positive Outlook for Alnylam Pharmaceuticals Citi has reaffirmed its Buy rating and a price target of $342.00 for Alnylam Pharmaceuticals (NASDAQ: ALNY). This supportive action follows Alnylam's recent TTR Investor Day presentation, which underscored the challenges and treatment needs related to transthyretin amyloid cardiomyopathy (ATTR-CM). The event...

Continue Reading
Orchid Island Capital's Monthly Dividend Announcement Update

Updated Category News Views 143

Updates on Orchid Island Capital's Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC) has officially declared a monthly cash dividend of $0.12 per share for May 2025, providing a continued commitment to shareholder returns. This dividend is slated for distribution to stockholders on June 27, 2025, ensuring that investors remain rewarded for their confidence in the...

Continue Reading
Rigel Pharmaceuticals: What to Expect from Upcoming Earnings

Updated Category News Views 140

Preparing for Rigel Pharmaceuticals' Quarterly Earnings Rigel Pharmaceuticals (NASDAQ:RIGL) is set to unveil its quarterly earnings soon. Investors may benefit from understanding key elements ahead of this important announcement. Expected Earnings Insights Analysts predict that Rigel Pharmaceuticals will report an earnings per share (EPS) of $0.85. This forecast reflects...

Continue Reading
Biodesix Announces Upcoming Presentation at Growth Conference

Updated Category News Views 138

Biodesix, Inc. Presentation at Major Growth Event Biodesix, Inc. (NASDAQ: BDSX), a pioneer in diagnostic solutions, is gearing up to present at the Canaccord Genuity 45th Annual Growth Conference. The event will showcase insights into the company's innovative approaches to enhancing clinical care and patient outcomes. Key Details of the Conference Engagement Scheduled for...

Continue Reading
Transforming Office Towers: Three Collective's Apartment Vision

Updated Category News Views 162

Three Collective Unveils Adaptive Apartment Community Welcome to the future of urban living! Three Collective, often referred to as 3co, represents a remarkable transformation of underutilized office towers into a modern and vibrant apartment community featuring 675 apartments and a wealth of amenities. Reimagining Office Spaces into Homes Driven by The Wolff Company's...

Continue Reading